Ataraxis AI Launches to Transform Precision Medicine Beginning with World’s First AI-native Cancer Diagnostic

Ataraxis AI, backed by $4M in seed funding, emerges from stealth and launches Ataraxis Breast — the world’s first AI-native breast cancer prognostic test, and Kestrel — a state-of-the-art AI foundation model for digital pathology.

In this NeurIPS 2024 Workshop paper, we demonstrate the importance of hyperparameter tuning in training digital pathology AI foundation models.

We describe the development and validation of Ataraxis Breast, the first AI-native breast cancer prognostication tool.